glp-1 agonist or antagonist The Premise of the Paradox: Examining the Evidence That Motivated GIPR and Drug Development Programs The therapeutic potential of GLP‐1

Promote renal calcium reabsorption Renal tubular calcium transport: upregulate the expression of renal tubular calcium channel (TRPV5), reduce urinary calcium excretion by 30% -40%, increase blood calcium concentration, and increase bone calcium deposition Evidence from preclinical studies on AOD 9604 bone protection (animal experiments) Postmenopausal osteoporosis (OVX rat model) Experimental Design: Animal: 6-month-old female SD rats underwent bilateral ovariectomy (OVX) to establish a postmenopausal osteoporosis model

9.1 kg for placebo

Frequency of chronic active Epstein-Barr virus infection in a general medical practice

Almost 10% of the United States is diabetic and it's increasing globally at an increasing rate84 million Americans are prediabetic and 70% will be diabetic within 10 years

Improves Metabolic Health Tesamorelin may improve insulin sensitivity and lower triglycerides